Diabetic nephropathy and pregnancy

Clinical Obstetrics and Gynecology

Volumn 50, Issue 4, 2007, Pages 998-1006

  Landon, Mark B ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetes in pregnancy; Diabetic nephropathy; Renal disease

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG SAFETY; FETUS OUTCOME; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; PATHOPHYSIOLOGY; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; RENAL PROTECTION; RISK ASSESSMENT; TERATOGENICITY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FETAL DISEASES; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, ANGIOTENSIN; RISK FACTORS; WOMEN'S HEALTH;

EID: 35848940700     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31815a6383     Document Type: Article

References (35)

1. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940.
2. Russo LM, Bakris GL, Comper WD. Renal handling of albumin: a critical review of basic concepts and perspective [Review]. Am J Kidney Dis. 2002;39:899.
3. Blouch K, Deem WM, Fauvel J-P, et al. Molecular configuration of glomerular size selectivity in healthy and nephritic humans. Am J Physiol. 1997;273:F430.
4. Mogensen CE, Schmitz O. The diabetic kidney: from hyperfiltration and microalbuminuria to endstage renal failure. Med Clin North Am. 1988;72:1465.
5. American Diabetes Association. Diabetic nephropathy. Position statement. Diabetes Care. 2002;25:585-589.
6. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1999;329:1456-1462.
7. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995;346:1080-1084.
8. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
9. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing the risk of macrovascular complications in type 2 diabetes. BMJ. 1998;317:713-720.
10. Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kid Dis. 2000;36:646-661.
11. Kasiske BL, Kalil RSN, Ma JZ, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993;118:129.
12. Euclid Study Group. Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet. 1997;349:1787.
13. Ravid M, Brosh D, Levi Z, et al. Use of Enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. Ann Intern Med. 1998;128:982.
14. Koomers R, Cooper ME. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins. Am J Physiol. 1995;268:F588.
15. Anderson S, Tarnow L, Rossing P, et al. Renoprotective effects of angiotensin II blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 2000;57:601.
16. Saji H, Yamanaka M, Hagiwara A, et al. Losartan and fetal toxic effects. Lancet. 2001;357:36319.
17. Cox RM, Anderson JM, Cox P. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy. Br J Obstet Gynaecol. 2003;110:1038.
18. Hod M, van Kijk DJ, Karp M, et al. Diabetic nephropathy and pregnancy: the effect of Ace inhibitors prior to pregnancy on maternal outcome. Nephrol Dial Transplant. 1995;10:2328.
19. Bar JB, Schoenfeld A, Orvieto R, et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab. 1999;12:659.
20. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations in first-trimester exposure to ACE inhibitors. NEJM. 2006;354L:2443-2451.
21. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy (Class F). Obstet Gynecol. 1996;87:401-409.
22. Kitzmiller JL, Brown ER, Phillippee M. Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol. 1981;141:741-751.
23. Reece EA, Coustan DR, Hayslett JP, et al. Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol. 1988;159:56-66.
24. Dunne FP, Chowdhury TA, Hartland A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. Q J Med. 1999;92:451-454.
25. Carr DB, Koontz GL, Gardella A, et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens. 2006;19:513-519.
26. Jovanovic R, Jovanovic L. Obstetric management when normoglycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol. 1984;149:617-623.
27. Biesenbach G, Zazgornik J. Incidence of transient nephrotic syndrome during pregnancy in diabetic women with and without pre-existing microalbuminuria. BMJ. 1989;299:366-367.
28. Grenfell A, Brudnell JM, Doddridge MC, et al. Pregnancy in diabetic women who have proteinuria. Q J Med. 1986;59:379.
29. Rosenn BM, Miodovnik M, Khoury JC, et al. Outcome of pregnancy in women with diabetic nephropathy. Am J Obstet Gynecol. 1997;176:S631.
30. Khoury JC, Miodovnik M, LeMasters G, et al. Pregnancy outcome and progression of diabetic nephropathy. What's next? J Matern Fetal Neonat Med. 2002;11:238.
31. Abe S. An overview of pregnancy in women with underlying renal disease. Am J Kidney Dis. 1991;17:112-115.
32. Rossing K, Jacobsen P, Hommel E, et al. Pregnancy and progression of diabetic nephropathy. Diabetologia. 2002;45:36-41.
33. Miodovnik M, Rosenn BM, Khoury JC, et al. Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol. 1996;174:1180.
34. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest. 1976;36:383-388.
35. Parving HH, Hovind P, Rossing K, et al. Evolving strategies for renoprotection diabetic nephropathy [Review]. Curr Opin Nephrol Hypertens. 2001;10:515.